Esoteric Testing Market Regional Analysis:
North American Market Insights
North America region is projected to account for more than 41.5% market share by 2035, attributed majorly to the well-established medical infrastructure, and high healthcare spending in the region. As per the data provided by the Centers for Medicare and Medicaid Services, healthcare spending in the United States grew 9.7% in 2020, reaching a value of USD 4.1 trillion or USD 12,530 per person. In addition to this, the increasing frequency of chronic disorders, coupled with the growing ratio of diagnostic tests, as well as the vast population base of aged people are also estimated to fuel the regional market growth. Furthermore, the escalating proportion of rare disorders, along with the surging investment in R&D activities for rare diseases is also anticipated to accelerate the growth of the esoteric testing market in the region.
Europe Market Insights
The European esoteric testing market is projected to grow with a notable CAGR during the forecast period, attributed majorly to the rising utilization of rapid diagnosis, followed by the technological advancements to develop enhanced precision medicine in the region.